7-143357421-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001031690.3(FAM131B):c.469G>A(p.Val157Ile) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000131 in 1,604,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001031690.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM131B | NM_001031690.3 | c.469G>A | p.Val157Ile | missense_variant, splice_region_variant | 6/7 | ENST00000443739.7 | NP_001026860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM131B | ENST00000443739.7 | c.469G>A | p.Val157Ile | missense_variant, splice_region_variant | 6/7 | 1 | NM_001031690.3 | ENSP00000410603.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152188Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000826 AC: 2AN: 242046Hom.: 0 AF XY: 0.0000153 AC XY: 2AN XY: 130856
GnomAD4 exome AF: 0.0000131 AC: 19AN: 1452324Hom.: 0 Cov.: 32 AF XY: 0.0000152 AC XY: 11AN XY: 721868
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152188Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.469G>A (p.V157I) alteration is located in exon 6 (coding exon 6) of the FAM131B gene. This alteration results from a G to A substitution at nucleotide position 469, causing the valine (V) at amino acid position 157 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at